Blog Posts

Two Drugmakers Appeal Federal District Judge’s 340B Rebate Ruling in Favor of HHS

Two drugmakers are appealing a Washington, D.C. federal district judge's ruling against unilateral 340B rebate models.
Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BI Asks Tennessee Contract Pharmacies to Report Claims Data Ahead of New State Law, BMS Updates Contract Pharmacy Restrictions

Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Health Center Group Motion Denied in 5th Circuit; Drug Industry Makes Motion in Federal Court in South Dakota 

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana and South Dakota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk, Merck, GSK to Refund 340B Covered Entities for Overcharges

Novo Nordisk, Merck and GSK announced they will refund covered entities following certain overcharges for 340B drugs.
Three drugmakers will refund covered entities that purchased certain 340B-priced medications following recent adjustments to their 340B drug ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Battlefront Shifts from Contract Pharmacies to Rebates

Ted Slafsky, publisher and CEO of 340B Report, writes on drugmaker efforts to convert upfront 340B discounts to a rebate model.
By the first week of June, we should have a better sense of how the Trump administration plans to address [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Expert Tip from CaptureRx

img
img

TIP: Use quarterly eRx data analysis to identify contract pharmacy expansion opportunities, including independent pharmacies.


Every quarter,

Read More »

News Alert

Oregon Senate Narrowly Passes 340B Contract Pharmacy Access Bill

The Oregon Senate recently passed an amended 340B contract pharmacy access bill.
Oregon state senators late yesterday narrowly passed legislation to prohibit drugmakers from restricting 340B contract pharmacy access in the state. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Defends 340B Hospital Drug Purchasing Restrictions Policy, Asks Federal Court to Reject Premier’s Challenge

HHS attorneys recently urged a Washington D.C. federal court to uphold a 2013 HRSA policy and reject Premier's claim that it unlawfully restricts how certain 340B hospitals can purchase initial drug inventory.
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House GOP Lawmaker Spartz Introduces Bill That 340B Provider Advocates Say Would Drive Them Out of the Program and Potentially Force Closures

U.S. Rep. Victoria Spartz (R-Ind.) introduced the legislation (H.R. 3222), known as the “Stopping Medicare Abuses to Restore Trust in Health Care Act” or SMART Health Care Act, on May 6. 340B provider advocates strongly oppose the bill's 340B provisions.
An Indiana congresswoman recently introduced a controversial U.S. House bill that could potentially require 340B covered entities to pass all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Don’t Overlook the Importance of an HIN on Your Wholesale Accounts

SPONSORED CONTENT

It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an easy and streamlined process. The Health Industry Number (HIN) was not something that was discussed very often prior to the manufacturer restrictions. The HIN is

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live